Ann: H1 FY23 - Nuheara Delivers on US Regulated Market Strategy, page-11

No more excuses now. Been in and out of NUH multiple times over the years with my last exit at the old 4 cents. Won some trades but definitely down overall. Got back in today so here's how I see it:

PROS
- New FDA approved product shipped.
- Sales channels lined up for HP PRO and ready to start selling.
- Realtek as cornerstone investor and what seems to be an OEM product already being marketed. This was news to me. I think this relationship is the future of NUH in my opinion.

CONS/CONCERNS
- Cash burn. Recent raise of a few million basically lasts a quarter. More raises on the way until revenue comes in. How much? Too many "Heavy Hitters" drawing a salary without any value being added in terms of $$$$.
- Market doesn't believe a word out of management's mouth after over promising and under delivering for years.
- Will the product actually sell in any type of volume ( form factor ) or are we waiting for smaller device and new Realtek collab.
- How many HP PRO products were shipped, in the dark here.

Probably need my head examined getting back in but worth a punt down here for me.